BAC
Bank of America Corporation
BAC has the edge over FRBA overall, supported by stronger modeled upside and stronger valuation.
FRBA
First Bank
FRBA's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
FRBA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
FRBA's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like FRBA.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over FRBA in the historical PE scenario, which offers more potential upside but is not a forecast.
FRBA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8x | $13.52 | -32% |
| Fair | 10x | $17.16 | -13% |
| Forward | 10x | $19.77 | — |
| Current | 12x | $19.77 | — |
| Expensive | 13x | $21.30 | +7.7% |
Historical ranges are pointers, not guarantees.
FRBA's PE is in its expensive range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over FRBA on the outlook, with more favorable profitability expectations.
FRBA Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for FRBA, with profitability holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over FRBA on earnings, with stronger typical year-over-year growth.
FRBA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.92 | +13% |
| Q2 2026 | $1.69 | +12% |
| Q1 2026 | $1.67 | +8.4% |
| Q4 2025 | $1.74 | +4.2% |
| Q3 2025 | $1.66 | +4.4% |
| Q2 2025 | $1.51 | +24% |
| Q1 2025 | $1.54 | +36% |
| Q4 2024 | $1.67 | +69% |
| Q3 2024 | $1.59 | +42% |
FRBA's earnings per share have climbed steadily: $1.69 over the past year, up 12% from the year before, and higher year over year for eight quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over FRBA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over FRBA on profitability, with a higher operating margin.
FRBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $59.4M | -4% |
| Q1 2026 | $58.2M | +0.8% |
| Q4 2025 | $64.5M | +9.4% |
| Q3 2025 | $63.6M | +8.4% |
| Q2 2025 | $61.9M | +10% |
| Q1 2025 | $57.8M | +4% |
| Q4 2024 | $59M | +18% |
| Q3 2024 | $58.6M | +17% |
FRBA's revenue has held roughly level: $59M last quarter, down 4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 25% | +3.1 points |
| Q1 2026 | 17% | -4 points |
| Q4 2025 | 26% | +1.3 points |
| Q3 2025 | 24% | +3 points |
| Q2 2025 | 21% | -2 points |
| Q1 2025 | 21% | -6.3 points |
| Q4 2024 | 24% | +3.8 points |
| Q3 2024 | 21% | +24 points |
FRBA's operating margin was 25% last quarter, up 3.1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over FRBA on cash flow, with more consistent year-over-year improvement.
FRBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $7.4M | -29% |
| Q1 2026 | $10.7M | -45% |
| Q4 2025 | $16.3M | +$29.1M |
| Q3 2025 | $16.3M | +$18.1M |
| Q2 2025 | $10.4M | -65% |
| Q1 2025 | $19.6M | +101% |
| Q4 2024 | -$12.8M | -133% |
| Q3 2024 | -$1.8M | -102% |
FRBA's free cash flow was $51M over the past year, about three times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like FRBA.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over FRBA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
FRBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.5% | -125K shares |
| 1 year | -0.6% | -159K shares |
| 3 years | +29% | +5.6M shares |
| 5 years | +26% | +5.2M shares |
| Available history | +32% | +6.1M shares |
FRBA has 25M diluted shares, down 0.6% from a year ago, with $7M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $5M |
| Q1 2026 | $521,000 |
| Q4 2025 | — |
| Q3 2025 | $1.8M |
| Q2 2025 | $2.8M |
| Q1 2025 | $3.9M |
| Q4 2024 | $1.3M |
| Q3 2024 | — |
FRBA spent $7M buying back its own shares over the past year, down 8.9% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
FRBA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 4.0x | High |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 1.0x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.3x | Very low |
| Q3 2024 | -0.7x | Net Cash |
FRBA has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
FRBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 70.1 | Neutral |
FRBA's weekly RSI is 68 (neutral) and its Stochastic is 70 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
FRBA PE vs Financial Services Sector
| Metric | FRBA | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 10% below |
| PE % | 70 | 63 | 7 pts above |
FRBA has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
FRBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.6 | 6.1% above |
| 20 week MA | $18.3 | 8% above |
| 50 week MA | $17.1 | 16% above |
| 100 week MA | $16.1 | 23% above |
| 200 week MA | $14.4 | 37% above |
FRBA has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
FRBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $11.0 | $9.52 | -13% |
| 2021 | $9.52 | $14.2 | +50% |
| 2022 | $14.2 | $14.0 | -1.7% |
| 2023 | $14.0 | $14.7 | +5% |
| 2024 | $14.7 | $14.0 | -4.7% |
| 2025 | $14.0 | $16.8 | +20% |
| 2026 YTD | $16.8 | $19.8 | +18% |
FRBA has the edge over BAC on returns for 2026, with the stronger performance.